Auxilium Pharmaceuticals
160 West Germantown Pike, Suite D-5
East Norriton
Pennsylvania
19401
United States
Tel: 610-239-8850
Fax: 610-239-8853
Website: http://www.auxiliuma2.com/
354 articles about Auxilium Pharmaceuticals
-
WindMIL Therapeutics, based in Baltimore, Maryland, filed a form D with the U.S. Securities and Exchange Commission, indicating it had raised $32.53 million in equity financing.
-
Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order
6/11/2018
Endo International plc announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC have executed a definitive master settlement agreement allowing for the resolution of all known testosterone replacement therapy product liability claims against the Company.
-
Endo International Kills Deals with Auxilium Pharma and Acerus
12/31/2015
-
Auxilium Pharmaceuticals Announces Fundamental Change And Make-Whole Fundamental Change Relating To Outstanding Convertible Senior Notes
2/3/2015
-
Endo Pharmaceuticals Completes Acquisition Of Auxilium Pharmaceuticals
1/30/2015
-
Auxilium Pharmaceuticals Announces Results From Special Meeting Of Stockholders
1/27/2015
-
Huge Payday Looming for Six Auxilium Pharmaceuticals Execs
1/26/2015
-
Auxilium Pharmaceuticals Release: Sobi's Xiapex Receives Positive Opinion By CHMP For The Treatment Of Peyronie's Disease
12/22/2014
-
Endo International Registration Statement Relating To Pending Auxilium Pharmaceuticals Acquisition Declared Effective By The SEC
12/12/2014
-
Auxilium Pharmaceuticals Announces Date For Special Meeting Of Stockholders
12/12/2014
-
Auxilium Pharmaceuticals Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting
11/20/2014
-
Auxilium Pharmaceuticals Presents STENDRA Data At SMSNA Scientific Meeting
11/20/2014
-
Endo Pharmaceuticals Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals
11/19/2014
-
Auxilium Pharmaceuticals To Present XIAFLEX And STENDRA Data At SMSNA Scientific Meeting
11/3/2014
-
Auxilium Pharmaceuticals Announces Third Quarter 2014 Financial Results
10/30/2014
-
Auxilium Pharmaceuticals Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients
10/21/2014
-
QLT Inc. Announces Merger With Auxilium Pharmaceuticals Terminates For Superior Proposal
10/9/2014
-
Endo International plc Pays $2.6 Billion For Auxilium Pharmaceuticals, Auxilium Drops QLT Inc. Deal
10/9/2014
-
Endo International plc Comments On Auxilium Pharmaceuticals' Rejection Of Its Acquisition Proposal
9/22/2014
-
Auxilium Pharmaceuticals Rejects $2.2B Bid From Endo International plc, While QLT Inc. Merger Looks More Likely
9/22/2014